| Name | Title | Contact Details |
|---|---|---|
Chris Rule |
Chief People Officer | Profile |
Scott Walker |
Chief Financial Officer | Profile |
Stephen Cassell |
Chief Marketing and Brand Officer | Profile |
Ashley Hague |
Vice President, MassHealth Product Strategy, Point32Health | Profile |
Javier Barrientos |
Chief Diversity, Equity and Inclusion Officer | Profile |
First Biomedical Inc is a Olathe, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Community health center with four locations in Spartanburg County and one in Cherokee County. We have a dental practice and a pharmacy.
Cayuga Medical Center is a 204-bed, state-of-the art regional medical center. The Medical Center’s mission is to deliver the highest quality health care and is affiliated with many prestigious health care organizations including Cornell University's Weill Medical College in New York City, Roswell Park Cancer Institute in Buffalo, NY, Rochester General Hospital’s Heart Institute and the Mayo Medical Laboratories. CMC received a silver award for “The Center Is You” campaign that rolled out in 2008.
University Emergency Physicians is a Cincinnati, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BERG is a Boston-based biopharma company focused on taking a bold “back to biology” approach to therapeutic discovery using its unique AI-based Interrogative Biology® platform. This platform combines patient biology and AI-based analytics to engage the differences between healthy and disease environments. The patient’s own biology drives the platform’s results and guides us in the discovery and development of drugs, diagnostics and healthcare applications. Our platform utilizes patient population health data to bring actionable Patient IntelligenceTM to precision medicine applications. For patients this means faster discovery and development of treatments, more effective precision treatments for individuals as well as a reduction in costs to our healthcare systems. BERG has a robust product portfolio in oncology, endocrinology and neurology with mature assets in oncology entering mid and late stage trials. BERG is committed to improving the lives of patients through precision medicine made possible by our innovative platforms.